- Home
- LOPE vs GH Comparison
LOPE vs GH Comparison
Compare LOPE & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LOPE | GH |
|---|---|---|
| Founded | 1949 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 22.9B |
| IPO Year | 2008 | 2018 |
Fundamental Metrics
Financial Performance| Metric | LOPE | GH |
|---|---|---|
| Price | $153.71 | $174.75 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 26 |
| Target Price | $195.00 | ★ $197.04 |
| AVG Volume (30 Days) | 270.1K | ★ 1.6M |
| Earning Date | 11-04-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 6.74 |
| EPS | ★ 4.57 | N/A |
| Revenue | $511,257,000.00 | ★ $982,021,000.00 |
| Revenue This Year | $5.61 | $38.25 |
| Revenue Next Year | $6.14 | $35.51 |
| P/E Ratio | $32.23 | ★ N/A |
| Revenue Growth | N/A | ★ 32.88 |
| 52 Week Low | $134.27 | $61.00 |
| 52 Week High | $223.04 | $183.51 |
Technical Indicators
Market Signals| Indicator | LOPE | GH |
|---|---|---|
| Relative Strength Index (RSI) | 57.00 | 58.97 |
| Support Level | $138.83 | $153.88 |
| Resistance Level | $156.72 | $183.51 |
| Average True Range (ATR) | 4.42 | 7.26 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 66.34 | 78.42 |
Price Performance
Historical ComparisonAbout LOPE Grand Canyon Education Inc.
Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges, both online and on the ground at its campus in Phoenix, Arizona, and at four off-site classroom andlaboratory sites. The Company generates all of its revenue through service agreements with its university partners.
About GH Guardant Health Inc.
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.